PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
March 1, 2024Journal of the American College of CardiologyOpen Access

Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDavid A. MorrowEVEric J. VelazquezADAkshay S. Desai

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morrow et al. (2024) studied this question.

synapsesocial.com/papers/68e761b8b6db6435876d78b9https://doi.org/10.1016/j.jacc.2024.01.027
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial2019 · 171 citations
  2. 2Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial2021 · 58 citations
  3. 3Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial2018 · 76 citations
  4. 4Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure2019 · 87 citations
  5. 5Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure2018 · 1,261 citations